NanoViricides
NNVC
#10582
Rank
C$42.82 M
Marketcap
C$1.68
Share price
-1.68%
Change (1 day)
-15.36%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$1.7 Million

According to NanoViricides's latest financial reports the company's total liabilities are C$1.7 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30C$1.77 M-4.32%
2024-06-30C$1.85 M-31%
2023-06-30C$2.69 M406.58%
2022-06-30C$0.53 M22.13%
2021-06-30C$0.43 M-85.13%
2020-06-30C$2.92 M-21.49%
2019-06-30C$3.72 M221.49%
2018-06-30C$1.15 M-86.64%
2017-06-30C$8.67 M-50.7%
2016-06-30C$17.6 M13.77%
2015-06-30C$15.47 M-29.24%
2014-06-30C$21.86 M147.66%
2013-06-30C$8.82 M387.25%
2012-06-30C$1.81 M220.19%
2011-06-30C$0.56 M-78.39%
2010-06-30C$2.61 M341.95%
2009-06-30C$0.59 M-43.22%
2008-06-30C$1.04 M15.84%
2007-06-30C$0.9 M-45.59%
2006-06-30C$1.65 M1920.56%
2005-06-30C$0.08 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
C$53.88 B 3,159,164.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$125.79 B 7,375,101.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$93.63 B 5,489,687.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$101.33 B 5,941,523.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C$1.64 B 96,167.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$1.44 B 84,902.35%๐Ÿ‡บ๐Ÿ‡ธ USA